A major breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently disabled in several types of cancer, https://nimmansocial.com/story12083568/vhh-fragments-revive-p53-the-promising-pathway-for-tumor-treatment